TriGemX Installs New CEO and CFO During Phase 3 Launch

Company TriGemX Bio (formerly Kallyope) Event Type Leadership Appointment Modality N/A (Corporate Leadership) Asset Elismetrep (K-304) Target N/A Disease Area Acute Migraine Summary TriGemX Bio appointed Jeff Goater chief executive officer and Aninda Katragadda chief financial officer as the renamed company raised $94 million and…